Back to Search
Start Over
127P A meta-analysis of efficacy and safety from head-to-head first-line (1L) trials of epidermal growth factor receptor inhibitors (EGFRIs) versus bevacizumab in combination with chemotherapy (CT) doublets in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) by sidedness
- Source :
-
Annals of Oncology . 2023 Supplement 4, Vol. 34, pS1519-S1519. 1p. - Publication Year :
- 2023
- Subjects :
- *EPIDERMAL growth factor receptors
*COMBINATION drug therapy
*BEVACIZUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 34
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 173758145
- Full Text :
- https://doi.org/10.1016/j.annonc.2023.10.262